Startup
Every investor coverage indicates participated in a round Biorithm raised.
| Investor | Rounds | Invested |
|---|---|---|
| MedTech Innovator | Accelerator | - |
| Philips | Accelerator | - |
Companies Biorithm acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Biorithm. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Maternal health medtech Biorithm, spun out of a Singapore university, has joined the 2021 MedTech Innovator Asia Pacific accelerator cohort, gaining mentorship, investor exposure, and a chance at US$300,000 in prizes.
Profile of women's health startup Biorithm covering its Femom remote fetal monitoring system, a bridge raise in progress, and its earlier selection for Philips' Healthworks program.